Selective Lymph Node Dissection for Castration-Resistant Prostate Cancer

Publisher： Karger

E-ISSN： 1423-0399|88|4|441-446

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.88, Iss.4, 2012-03, pp. : 441-446

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Methylselenocysteine preventing castration‐resistant progression of prostate cancer

By  

THE PROSTATE, Vol. 75, Iss. 9, 2015-06 ,pp. : 1001-1008

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of Immunotherapy in Castration‐Resistant Prostate Cancer (CRPC)

By  

BJU INTERNATIONAL, Vol. 113, Iss. 3, 2014-03 ,pp. : 367-375

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Role of Palliative Surgery in Castration-Resistant Prostate Cancer

By  

Oncology Research and Treatment, Vol. 38, Iss. 12, 2015-0 ,pp. : 670-677

Karger

Access to resources Recommend Favorite

Is prostate cancer changing?: Evolving patterns of metastatic castration‐resistant prostate cancer

By  

CANCER, Vol. 120, Iss. 6, 2014-03 ,pp. : 833-839

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Outcome of Patients with Lymph Node-Positive Prostate Cancer following Radical Prostatectomy and Extended Sentinel Lymph Node Dissection

By  

Urologia Internationalis, Vol. 94, Iss. 3, 2014-08 ,pp. : 296-306

Karger

Access to resources Recommend Favorite